Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Papillomavirus Infections 11Neoplasms 10Uterine Cervical Neoplasms 8Breast Neoplasms 8Condylomata Acuminata 5Prostatic Neoplasms 4Melanoma 4Anus Neoplasms 4Vulvar Neoplasms 3Uterine Cervical Dysplasia 3Lung Neoplasms 3Herpes Zoster 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Vaginal Neoplasms 2Sarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Influenza, Human 2HIV Infections 2Glioma 2Colonic Neoplasms 2Breast Neoplasms, Male 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1

Interventions

Vincristine 16Cyclophosphamide 16Filgrastim 13Etoposide 12Doxorubicin 12Radiotherapy 11Carboplatin 10X-Rays 9Dactinomycin 9Specimen Handling 8Phantoms, Imaging 8Magnetic Resonance Spectroscopy 8Granulocyte Colony-Stimulating Factor 8Temozolomide 6Melphalan 6Ifosfamide 6Topotecan 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Irinotecan 5Busulfan 5Biopsy 5sargramostim 4Stem Cell Transplantation 4Thiotepa 3Radiation 3Nivolumab 3Mesna 3Itraconazole 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Wilms Tumor × Vaccines × Clear all
NCT00405327 2017-11-06

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

University of Michigan Rogel Cancer Center

Phase 2 Completed
16 enrolled
CNSGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡